You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

T-cell priming

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Relapsed or Refractory T-cell Lymphomas Trial in Sendai-shi (BMS-986369)

Not yet recruiting
  • Relapsed or Refractory T-cell Lymphomas
  • Sendai-shi, Miyagi, Japan
    Local Institution - 0001
Sep 12, 2023

Lymphoblastic Lymphoma, T-Cell Lymphoblastic Leukemia/Lymphoma, Lymphoblastic Leukemia Trial in Philadelphia (BEAM-201)

Recruiting
  • Lymphoblastic Lymphoma
  • +2 more
  • BEAM-201
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
Jun 2, 2023

Cervical Cancer, Head and Neck Squamous Cell Carcinoma, Oropharyngeal Cancer Trial in Shanghai (Fludarabine + Cyclophosphamide,

Not yet recruiting
  • Cervical Cancer
  • +6 more
  • Fludarabine + Cyclophosphamide
  • HRYZ-T101 TCR-T Cell
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Mar 27, 2023

T-Cell and NK-Cell Tumor Trial

Not yet recruiting
  • T-Cell and NK-Cell Neoplasm
    • (no location specified)
    Sep 28, 2023

    T-cell Acute Lymphoblastic Leukemia, T-lymphoblastic Lymphoma Trial in Kunming (Target CD7 CAR-T cells)

    Withdrawn
    • T-cell Acute Lymphoblastic Leukemia
    • T-lymphoblastic Lymphoma
    • Target CD7 CAR-T cells
    • Kunming, Yunnan, China
      920th Hospital of Joint Logistics Support Force of People's Libe
    Nov 23, 2022

    Metastatic Colorectal Adenocarcinoma, Metastatic Lung Non-Small Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma Trial in

    Not yet recruiting
    • Metastatic Colorectal Adenocarcinoma
    • +5 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Sep 12, 2023

    B Cell Malignancies Trial in Beijing, Shenzhen, Haikou (Universal CD19-specific CAR gene-engineered T cells)

    Recruiting
    • B Cell Malignancies
    • Universal CD19-specific CAR gene-engineered T cells
    • Beijing, Beijing, China
    • +2 more
    Aug 8, 2023

    NK-T-Cell Lymphoma, Extranodal Trial in Shanghai (4 cycles of ESA regimen with sandwiched radiotherapy, 2 cycles of ESA regimen

    Not yet recruiting
    • NK-T-Cell Lymphoma, Extranodal
    • 4 cycles of ESA regimen with sandwiched radiotherapy
    • +2 more
    • Shanghai, Shanghai, China
      Ruijin Hospital
    Sep 29, 2023

    Newly Diagnosed Peripheral T-cell Lymphoma Trial in Wuhan (Duvelisib, Chidamide)

    Recruiting
    • Newly Diagnosed Peripheral T-cell Lymphoma
    • Duvelisib, Chidamide
    • Wuhan, Hubei, China
      Union Hospital, Tongji Medical College, Huazhong University of S
    Jul 27, 2023

    Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL) Trial (GFH009)

    Not yet recruiting
    • Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)
    • (no location specified)
    Jun 28, 2023

    Lymphoma, T-Cell, Cutaneous, Hodgkin Disease, Lymphoma, T-Cell, Peripheral Trial (SGN-35T)

    Not yet recruiting
    • Lymphoma, T-Cell, Cutaneous
    • +5 more
    • (no location specified)
    Nov 2, 2023

    Non Hodgkin's Lymphoma Trial in Beijing (TRAC and Power3 Genes Knock-out Allogeneic CD19-targeting CAR-T cell (ATHENA CAR-T),

    Not yet recruiting
    • Non Hodgkin's Lymphoma
    • TRAC and Power3 Genes Knock-out Allogeneic CD19-targeting CAR-T cell (ATHENA CAR-T)
    • +2 more
    • Beijing, China
    • +2 more
    Aug 23, 2023

    Recurrent DLBCL, Refractory DLBCL Trial in Duarte (procedure, biological, radiation)

    Not yet recruiting
    • Recurrent Diffuse Large B-Cell Lymphoma
    • Refractory Diffuse Large B-Cell Lymphoma
    • Biospecimen Collection
    • +6 more
    • Duarte, California
      City of Hope Medical Center
    Mar 24, 2023

    T Lymphoblastic Leukemia/Lymphoma Trial in Shenzhen (CD7 CAR-T cells)

    Recruiting
    • T Lymphoblastic Leukemia/Lymphoma
    • CD7 CAR-T cells
    • Shenzhen, Guangdong, China
      Li Yu
    Nov 11, 2022

    Follicular Lymphoma, B-Cell Lymphoma, Mantle Cell Lymphoma Trial in New York (Tazemetostat Pill)

    Not yet recruiting
    • Follicular Lymphoma
    • +3 more
    • Tazemetostat Pill
    • New York, New York
      Weill Cornell Medicine/NewYork-Presbyterian Hospital
    Jun 28, 2023

    nk/T-cell Lymphoma, Newly Diagnosed, Advanced Lymphoma Trial in Beijing (XPO1 inhibitor)

    Recruiting
    • nk/T-cell Lymphoma
    • +2 more
    • XPO1 inhibitor
    • Beijing, Haidian, China
      ChinaPLAGH
    Apr 18, 2023

    T-cell Lymphoma, CLL/SLL Trial in Birmingham (Tazemetostat, Acalabrutinib and Tazemetostat)

    Not yet recruiting
    • T-cell Lymphoma
    • CLL/SLL
    • Birmingham, Alabama
      University of Alabama at Birmingham
    Aug 11, 2023

    Prostate Carcinoma, Prostate Small Cell Neuroendocrine Carcinoma, Stage III Prostate Cancer AJCC v8 Trial in Seattle (drug,

    Not yet recruiting
    • Prostate Carcinoma
    • +3 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Oct 17, 2023

    B-cell Acute Lymphoblastic Leukemia, B-Cell Lymphoma, Unspecified Trial in Guangzhou, Guanzhou (CD19 CAR T-Cell(CAT19T2))

    Not yet recruiting
    • B-cell Acute Lymphoblastic Leukemia
    • B-Cell Lymphoma, Unspecified
    • CD19 CAR T-Cell(CAT19T2)
    • Guangzhou, Guangdong, China
    • +1 more
    Nov 4, 2022

    Kidney Transplant, Kidney Failure, Highly Sensitized Trial in Boston, New York, Philadelphia (Cyclophosphamide, CART-BCMA,

    Not yet recruiting
    • Kidney Transplant
    • +2 more
    • Boston, Massachusetts
    • +2 more
    Sep 20, 2023

    CX3CR1+T Cell Predict Immunotherapy Efficacy

    Recruiting
    • Non-small Cell Lung Cancer
    • PD-1 inhibitor based immunotherapy
    • Changsha, Hunan, China
    • +1 more
    Sep 19, 2023

    Peripheral T Cell Lymphoma Trial in Zhengzhou (Golidocitinib, CHOP Regimen)

    Not yet recruiting
    • Peripheral T Cell Lymphoma
    • Zhengzhou, Henan, China
      Henan Cancer Hospital
    Jul 18, 2023

    B-cell Lymphoma Trial in Stockholm, Uppsala (CAR20(NAP)-T, Cyclophosphamide, Fludarabine)

    Not yet recruiting
    • B-cell Lymphoma
    • CAR20(NAP)-T
    • +2 more
    • Stockholm, Sweden
    • +1 more
    Aug 15, 2023

    Large B-cell Lymphoma, Relapsed Non-Hodgkin Lymphoma Trial in Tampa (Comprehensive Ablative Bridging Irradiation (CABI),

    Recruiting
    • Large B-cell Lymphoma
    • Relapsed Non-Hodgkin Lymphoma
    • Comprehensive Ablative Bridging Irradiation (CABI)
    • Chimeric Antigen Receptor T-Cell Therapy
    • Tampa, Florida
      Moffitt Cancer Center
    Oct 26, 2023

    Peripheral T Cell Lymphoma Trial in Shandong, Shanghai, Sichuan (84-gene penal)

    Not yet recruiting
    • Peripheral T Cell Lymphoma
    • 84-gene penal
    • Shandong, China
    • +2 more
    Jul 6, 2023